Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
2000 1
2001 2
2002 2
2004 3
2005 2
2006 1
2007 3
2008 30
2009 27
2010 30
2011 39
2012 37
2013 177
2014 359
2015 272
2016 198
2017 104
2018 48
2019 38
2020 68
2021 160
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

1,333 results
Results by year
Filters applied: . Clear all
Page 1
Epigenetics in ovarian cancer.
Natanzon Y, Goode EL, Cunningham JM. Natanzon Y, et al. Semin Cancer Biol. 2018 Aug;51:160-169. doi: 10.1016/j.semcancer.2017.08.003. Epub 2017 Aug 3. Semin Cancer Biol. 2018. PMID: 28782606 Free PMC article. Review.
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.
Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D. Basch E, et al. J Clin Oncol. 2016 Feb 20;34(6):557-65. doi: 10.1200/JCO.2015.63.0830. Epub 2015 Dec 7. J Clin Oncol. 2016. PMID: 26644527 Free PMC article. Clinical Trial.
Protocadherin 7-Associated Membranous Nephropathy.
Sethi S, Madden B, Debiec H, Morelle J, Charlesworth MC, Gross L, Negron V, Buob D, Chaudhry S, Jadoul M, Fervenza FC, Ronco P. Sethi S, et al. J Am Soc Nephrol. 2021 May 3;32(5):1249-1261. doi: 10.1681/ASN.2020081165. Epub 2021 Apr 8. J Am Soc Nephrol. 2021. PMID: 33833079 Free PMC article.
Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, Hummel AM, Specks U, Fervenza FC, Ronco P. Sethi S, et al. J Am Soc Nephrol. 2019 Jun;30(6):1123-1136. doi: 10.1681/ASN.2018080852. Epub 2019 May 6. J Am Soc Nephrol. 2019. PMID: 31061139 Free PMC article.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J, Loriot Y, Necchi A, Hoffman-Censits J, Perez-Gracia JL, Dawson NA, van der Heijden MS, Dreicer R, Srinivas S, Retz MM, Joseph RW, Drakaki A, Vaishampayan UN, Sridhar SS, Quinn DI, Durán I, Shaffer DR, Eigl BJ, Grivas PD, Yu EY, Li S, Kadel EE 3rd, Boyd Z, Bourgon R, Hegde PS, Mariathasan S, Thåström A, Abidoye OO, Fine GD, Bajorin DF; IMvigor210 Study Group. Balar AV, et al. Lancet. 2017 Jan 7;389(10064):67-76. doi: 10.1016/S0140-6736(16)32455-2. Epub 2016 Dec 8. Lancet. 2017. PMID: 27939400 Free PMC article. Clinical Trial.
Implication of TIGIT+ human memory B cells in immune regulation.
Hasan MM, Nair SS, O'Leary JG, Thompson-Snipes L, Nyarige V, Wang J, Park W, Stegall M, Heilman R, Klintmalm GB, Joo H, Oh S. Hasan MM, et al. Nat Commun. 2021 Mar 9;12(1):1534. doi: 10.1038/s41467-021-21413-y. Nat Commun. 2021. PMID: 33750787 Free PMC article.
Functional assays for analysis of variants of uncertain significance in BRCA2.
Guidugli L, Carreira A, Caputo SM, Ehlen A, Galli A, Monteiro AN, Neuhausen SL, Hansen TV, Couch FJ, Vreeswijk MP; ENIGMA consortium. Guidugli L, et al. Hum Mutat. 2014 Feb;35(2):151-64. doi: 10.1002/humu.22478. Epub 2013 Dec 3. Hum Mutat. 2014. PMID: 24323938 Free PMC article. Review.
1,333 results